iStock-1251136417.jpg
Clinically Studied Joint Health Support

Walking. Shopping. Climbing stairs. Household chores. Q-actin™ helps alleviate joint discomfort and improve flexibility so individuals can more easily perform these and other everyday activities, according to a clinical study published in the Clinical Interventions in Aging. In fact, Q-actin was significantly more effective than glucosamine-chondroitin in relieving knee discomfort and increasing mobility in subjects with moderate joint health issues related to age.

 

The randomized, double-blind clinical trial evaluated 122 men and women ages 40-75 in three countries. Study participants consumed either 1,350 mg of glucosamine-chondroitin or 10 mgs of Q-actin twice daily for six months. 

 

Individuals were evaluated at 30, 60, 90, 120 and 180 days using validated measures for pain and physical function that are widely accepted by physicians and other health care professionals. These include the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Visual Analogue Scale (VAS) and Lequesne's Functional Index (LFI).

 

The study demonstrates the ability of Q-actin to help restore, maintain and protect joint health, which is critical to older adults, elite and recreational athletes, and people struggling with body weight issues.

Q-actin reduces WOMAC score 70% over 6 months in a direct clinical comparison with glucosamine/ chondroitin

© 2020 by IminoTech, Inc.